Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus. / Knop, F.K.; Lauritsen, Tina Vilsbøll; Madsbad, Sten; Holst, J.J.; Krarup, T.; Knop, F K; Vilsbøll, Tina; Madsbad, S; Holst, Jens Møller; Krarup, T.

In: Diabetologia, Vol. 50, No. 4, 01.04.2007, p. 797-805.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Knop, FK, Lauritsen, TV, Madsbad, S, Holst, JJ, Krarup, T, Knop, FK, Vilsbøll, T, Madsbad, S, Holst, JM & Krarup, T 2007, 'Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus', Diabetologia, vol. 50, no. 4, pp. 797-805. https://doi.org/10.1007/s00125-006-0566-z

APA

Knop, F. K., Lauritsen, T. V., Madsbad, S., Holst, J. J., Krarup, T., Knop, F. K., Vilsbøll, T., Madsbad, S., Holst, J. M., & Krarup, T. (2007). Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus. Diabetologia, 50(4), 797-805. https://doi.org/10.1007/s00125-006-0566-z

Vancouver

Knop FK, Lauritsen TV, Madsbad S, Holst JJ, Krarup T, Knop FK et al. Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus. Diabetologia. 2007 Apr 1;50(4):797-805. https://doi.org/10.1007/s00125-006-0566-z

Author

Knop, F.K. ; Lauritsen, Tina Vilsbøll ; Madsbad, Sten ; Holst, J.J. ; Krarup, T. ; Knop, F K ; Vilsbøll, Tina ; Madsbad, S ; Holst, Jens Møller ; Krarup, T. / Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus. In: Diabetologia. 2007 ; Vol. 50, No. 4. pp. 797-805.

Bibtex

@article{334e67d020ec11ddbc23000ea68e967b,
title = "Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus",
abstract = "We investigated glucagon responses during OGTT and isoglycaemic i.v. glucose infusion, respectively, to further elucidate the mechanisms behind the glucose intolerance in patients with type 2 diabetes.",
author = "F.K. Knop and Lauritsen, {Tina Vilsb{\o}ll} and Sten Madsbad and J.J. Holst and T. Krarup and Knop, {F K} and Tina Vilsb{\o}ll and S Madsbad and Holst, {Jens M{\o}ller} and T Krarup",
year = "2007",
month = apr,
day = "1",
doi = "http://dx.doi.org/10.1007/s00125-006-0566-z",
language = "English",
volume = "50",
pages = "797--805",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer",
number = "4",

}

RIS

TY - JOUR

T1 - Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus

AU - Knop, F.K.

AU - Lauritsen, Tina Vilsbøll

AU - Madsbad, Sten

AU - Holst, J.J.

AU - Krarup, T.

AU - Knop, F K

AU - Vilsbøll, Tina

AU - Madsbad, S

AU - Holst, Jens Møller

AU - Krarup, T

PY - 2007/4/1

Y1 - 2007/4/1

N2 - We investigated glucagon responses during OGTT and isoglycaemic i.v. glucose infusion, respectively, to further elucidate the mechanisms behind the glucose intolerance in patients with type 2 diabetes.

AB - We investigated glucagon responses during OGTT and isoglycaemic i.v. glucose infusion, respectively, to further elucidate the mechanisms behind the glucose intolerance in patients with type 2 diabetes.

U2 - http://dx.doi.org/10.1007/s00125-006-0566-z

DO - http://dx.doi.org/10.1007/s00125-006-0566-z

M3 - Journal article

VL - 50

SP - 797

EP - 805

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 4

ER -

ID: 4038022